Business Description
Aclarion Inc
NAICS : 923120
SIC : 5045
ISIN : US6551874091
Share Class Description:
FRA:IT20: Ordinary SharesTotal Employee Number:
11Description
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.95 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.21 | |||||
Beneish M-Score | -4.12 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | 95.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 67.76 | |||||
9-Day RSI | 55.47 | |||||
14-Day RSI | 51.11 | |||||
3-1 Month Momentum % | 2.9 | |||||
6-1 Month Momentum % | -23.66 | |||||
12-1 Month Momentum % | -55.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 19.65 | |||||
Quick Ratio | 19.65 | |||||
Cash Ratio | 19.27 | |||||
Days Sales Outstanding | 135.57 | |||||
Days Payable | 2300.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -13.75 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 19.48 | |||||
Operating Margin % | -11101.3 | |||||
Net Margin % | -10454.55 | |||||
EBITDA Margin % | -10324.68 | |||||
FCF Margin % | -9890.77 | |||||
OCF Margin % | -9661.54 | |||||
ROE % | -53.69 | |||||
ROA % | -51.11 | |||||
ROIC % | -531.66 | |||||
3-Year ROIIC % | -420.9 | |||||
ROC (Joel Greenblatt) % | -33536.89 | |||||
ROCE % | -54.58 | |||||
Moat Score | 1 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 30.6 | |||||
PB Ratio | 0.38 | |||||
Price-to-Tangible-Book | 0.41 | |||||
EV-to-EBIT | -0.87 | |||||
EV-to-EBITDA | -0.9 | |||||
EV-to-Revenue | 92.71 | |||||
EV-to-FCF | -0.96 | |||||
| Price-to-Net-Current-Asset-Value | 0.41 | |||||
| Price-to-Net-Cash | 0.42 | |||||
Earnings Yield (Greenblatt) % | -114.94 | |||||
FCF Yield % | -99.14 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aclarion Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.065 | ||
| EPS (TTM) (€) | -7.756 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 53.73 | ||
| 14-Day RSI | 51.11 | ||
| 14-Day ATR (€) | 0.081299 | ||
| 20-Day SMA (€) | 2.463 | ||
| 12-1 Month Momentum % | -55.06 | ||
| 52-Week Range (€) | 1.8 - 10.3 | ||
| Shares Outstanding (Mil) | 2.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aclarion Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aclarion Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-12 | In 129 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 39 days | ||
| Guidance call for 2026 | 2026-06-17 08:30 | 2.42 (+0.00%) | ||
| General meeting for 2026 | 2026-06-04 14:30 | 2.84 (+0.71%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 2.44 (+0.00%) | ||
| Annual report for 2025 | 2026-03-18 | 2.60 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-12 | 6.06 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 6.40 (+5.96%) | ||
| General meeting for 2025 | 2025-07-07 09:30 | 6.14 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-05-15 | -- |
Show
Entries
Aclarion Inc Frequently Asked Questions
What is Aclarion Inc(FRA:IT20)'s stock price today?
The current price of FRA:IT20 is €2.50. The 52 week high of FRA:IT20 is €10.30 and 52 week low is €1.80.
When is next earnings date of Aclarion Inc(FRA:IT20)?
The next earnings date of Aclarion Inc(FRA:IT20) is 2026-08-14 Est..
Does Aclarion Inc(FRA:IT20) pay dividends? If so, how much?
Aclarion Inc(FRA:IT20) does not pay dividend.
Press Release
Articles on Aclarion Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers